Structural basis of lenacapavir-induced HIV-1 capsid defects during virion maturation
|
Long-acting lenacapavir (LEN) has emerged as a highly
effective, potentially game-changing therapy for HIV treatment and
prevention. |
New once-weekly HIV pill matches daily treatment in phase 3 trial
Living with HIV often means taking antiretroviral treatment every day to keep the virus under control. While modern HIV medicines have made it ... View article...